Complete Filing Data
HUTCHMED (China) Ltd reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $1.25 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean HUTCHMED (China) Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $456.9M | $37.7M | $100.8M | -$360.8M | -$194.6M | -$125.7M | -$106.0M | -$74.8M | -$26.7M | $11.7M | $8.0M | -$7.3M |
| Cost of Revenue * | $336.3M | $348.9M | $384.4M | $311.1M | $169.8M | $149.1M | $104.9M | $53.5M | ||||
| Revenue * | $548.5M | $630.2M | $838.0M | $426.4M | $356.1M | $228.0M | $204.9M | $214.1M | $241.2M | $216.1M | $178.2M | $87.3M |
| Research And Development Expense | $148.3M | $212.1M | $302.0M | $386.9M | $299.1M | $174.8M | $138.2M | $114.2M | $75.5M | $66.9M | $47.4M | $29.9M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $2.5M | -$3.8M | -$6.6M | -$8.5M | $3.0M | $9.5M | -$4.3M | -$6.6M | $11.0M | -$10.7M | -$5.6M | -$2.7M |
| Operating Income Loss | -$39.2M | -$43.7M | $18.4M | -$407.7M | -$328.3M | -$196.7M | -$146.4M | -$92.6M | -$53.4M | -$46.7M | -$9.8M | -$18.3M |
| Net Income Loss Attributable To Noncontrolling Interest | $823.0K | $441.0K | $314.0K | $449.0K | $27.6M | $10.2M | $2.3M | $3.5M | $3.8M | $2.9M | $2.4M | $3.2M |
| Income Tax Expense Benefit | $63.6M | $7.2M | $4.5M | -$283.0K | $11.9M | $4.8M | $3.3M | $4.0M | $3.1M | $4.3M | $1.6M | $1.3M |
| Income Loss From Equity Method Investments | $22.7M | $46.5M | $47.3M | $49.8M | $60.6M | $79.0M | $40.7M | $19.3M | $33.7M | $66.2M | $22.6M | $15.2M |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $498.7M | -$1.1M | $58.3M | -$410.4M | -$215.7M | -$189.7M | -$141.1M | -$86.7M | -$53.5M | -$47.4M | -$10.5M | -$20.0M |
| General And Administrative Expense | $66.7M | $64.3M | $79.8M | $92.2M | $89.3M | $50.0M | $39.2M | $30.9M | $24.0M | $21.6M | $19.6M | $12.7M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $460.2M | $34.4M | $94.5M | -$368.9M | -$164.1M | -$106.0M | -$108.0M | -$77.9M | -$12.0M | $3.8M | $4.9M | -$6.8M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $1.4M | $110.0K | -$39.0K | -$545.0K | $28.0M | $11.4M | $1.6M | $2.6M | $5.0M | $1.4M | $1.7M | $2.9M |
| Comprehensive Income Net Of Tax | $458.9M | $34.3M | $94.5M | -$368.3M | -$192.1M | -$117.4M | -$109.6M | -$80.5M | -$17.0M | $2.4M | $3.1M | -$9.7M |
| Nonoperating Income Expense | $61.0M | $42.6M | $39.9M | -$2.7M | -$8.7M | $6.9M | $5.3M | $6.0M | -$119.0K | -$659.0K | -$769.0K | -$1.7M |
| Accrued Income Taxes Current | $2.1M | $1.5M | $2.6M | $1.1M | $15.5M | $1.1M | $1.8M | $555.0K | $979.0K | $274.0K | $442.0K | $112.0K |
| Accounts Payable Accrued Liabilities Deferred Revenue Other Current | $271.4M | $264.6M | $210.8M | $121.3M | $81.6M | $56.3M | $41.0M | $31.7M | ||||
| Other Nonoperating Income | $19.7M | $10.3M | $12.9M | $1.8M | $2.4M | $4.6M | $1.9M | $1.8M | $808.0K | $609.0K | $386.0K | $20.0K |
| Income Taxes Paid Net | $62.4M | $3.6M | $3.7M | $18.9M | $5.0M | $5.9M | $3.2M | $3.8M | $3.8M | $2.7M | $510.0K | -$908.0K |
| Other Nonoperating Expense | $5.8M | $4.9M | $8.4M | $13.5M | $12.6M | $115.0K | $488.0K | $781.0K | $692.0K | $139.0K | $202.0K | |
| Interest Expense | $759.0K | $652.0K | $592.0K | $787.0K | $1.0M | $1.0M | $1.5M | $1.6M | $1.4M | $1.5M | ||
| Income Loss From Continuing Operations Per Diluted Share | $0.20 | -$0.64 | -$0.64 | |||||||||
| Income Loss From Continuing Operations Per Basic Share | $0.20 | -$0.64 | -$0.64 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.24B | $759.9M | $730.5M | $610.4M | $986.9M | $484.1M | $288.0M | $389.0M | $461.7M | $184.3M | $83.4M | $56.9M | $78.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $71.3M | $154.0M | $283.6M | $313.3M | $377.5M | $235.6M | $121.2M | $86.0M | $85.3M | $79.4M | $31.9M | ||
| Cash And Cash Equivalents At Carrying Value | $71.3M | $154.0M | $283.6M | $313.3M | $377.5M | $235.6M | $121.2M | $86.0M | $85.3M | $79.4M | $31.9M | $38.9M | $46.9M |
| Property Plant And Equipment Net | $94.6M | $92.5M | $99.7M | $75.9M | $41.3M | $24.2M | $20.9M | $16.6M | $14.2M | $10.0M | $8.5M | ||
| Retained Earnings Accumulated Deficit | -$378.6M | -$833.2M | -$870.9M | -$971.5M | -$610.3M | -$415.6M | -$289.7M | -$183.0M | -$107.1M | -$80.4M | -$92.0M | ||
| Minority Interest | $13.3M | $11.9M | $12.8M | $26.5M | $52.6M | $34.8M | $24.9M | $23.3M | $23.2M | $19.8M | $18.9M | ||
| Liabilities Current | $315.8M | $376.6M | $403.0M | $353.9M | $311.7M | $158.4M | $113.1M | $85.5M | $104.6M | $95.1M | $81.1M | ||
| Liabilities And Stockholders Equity | $1.75B | $1.27B | $1.28B | $1.03B | $1.37B | $724.1M | $465.1M | $532.1M | $597.9M | $342.4M | $229.6M | ||
| Liabilities | $501.8M | $502.3M | $536.4M | $392.6M | $333.1M | $205.2M | $152.2M | $119.9M | $113.0M | $138.4M | $127.3M | ||
| Inventory Net | $41.1M | $50.4M | $50.3M | $56.7M | $35.8M | $19.8M | $16.2M | $12.3M | $11.8M | $12.8M | $9.6M | ||
| Equity Method Investments | $10.9M | $77.8M | $48.4M | $73.8M | $76.5M | $139.5M | $98.9M | $138.3M | $144.2M | $158.5M | $119.8M | ||
| Common Stock Value | $87.2M | $87.2M | $87.1M | $86.5M | $86.5M | $72.8M | $66.7M | $66.7M | $66.4M | $60.7M | $56.5M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$82.6M | -$129.6M | -$29.7M | -$64.3M | $141.9M | $114.5M | $35.1M | $771.0K | $5.8M | $47.5M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$86.2M | -$126.2M | -$23.2M | -$54.8M | $139.5M | $108.9M | $36.6M | $2.7M | $3.5M | $49.3M | |||
| Assets Current | $1.57B | $1.07B | $1.10B | $839.9M | $1.21B | $530.7M | $317.0M | $370.5M | $432.2M | $167.4M | $89.5M | ||
| Assets | $1.75B | $1.27B | $1.28B | $1.03B | $1.37B | $724.1M | $465.1M | $532.1M | $597.9M | $342.4M | $229.6M | ||
| Additional Paid In Capital Common Stock | $1.53B | $1.52B | $1.52B | $1.50B | $1.51B | $822.5M | $514.9M | $505.6M | $497.0M | $208.2M | $113.8M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$4.5M | -$11.6M | -$8.2M | -$1.9M | $5.6M | $4.5M | -$3.8M | -$243.0K | $5.4M | -$4.3M | $5.0M | ||
| Accounts Receivable Net Current | $126.8M | $155.5M | $116.9M | $98.0M | $83.6M | $47.9M | $41.4M | $40.2M | $38.4M | $40.8M | $33.3M | ||
| Accounts Payable Current | $45.5M | $42.5M | $36.3M | $71.1M | $41.2M | $31.6M | $24.0M | $25.6M | $24.4M | $35.5M | $20.6M | ||
| Short Term Investments | $1.30B | $682.2M | $602.7M | $317.7M | $634.2M | $199.5M | $96.0M | $214.9M | $273.0M | $24.3M | $0.00 | ||
| Other Liabilities Noncurrent | $10.8M | $11.3M | $12.5M | $11.6M | $8.8M | $6.0M | $2.4M | $1.1M | $8.1M | $10.4M | |||
| Minority Interest Decrease From Distributions To Noncontrolling Interest Holders | $1.0M | $9.1M | $25.6M | $9.9M | $1.5M | $2.6M | $1.6M | $564.0K | $590.0K | $1.2M | |||
| Repayments Of Bank Debt | $24.6M | $30.6M | $26.9M | $26.9M | $30.0M | $49.5M | $28.2M | $6.4M | $11.3M | ||||
| Other Receivables Prepayments And Deposits Current | $21.8M | $16.6M | $14.9M | $53.2M | $81.0M | $27.9M | $15.8M | $13.4M | $11.3M | $4.3M | |||
| Other Assets Noncurrent | $20.1M | $12.4M | $14.7M | $15.7M | $21.6M | $20.2M | $5.8M | ||||||
| Long Term Debt Noncurrent | $68.2M | $59.4M | $48.2M | $18.1M | $26.9M | $26.8M | $26.7M | $26.8M | $26.8M | ||||
| Other Liabilities Current | $17.1M | $17.2M | $4.4M | ||||||||||
| Operating Lease Right Of Use Asset | $3.0M | $4.5M | $4.7M | $8.7M | $11.9M | $8.0M | $5.5M | $5.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $1.6M | $790.0K | $5.1M | $174.0K | $717.3M | $318.9M | $251.0K | $3.9M | $301.7M | $110.6M | $1.4M | $2.7M |
| Payments To Acquire Property Plant And Equipment | $14.1M | $17.9M | $32.6M | $36.7M | $16.4M | $7.9M | $8.6M | $6.4M | $5.0M | $4.3M | $3.3M | $3.7M |
| Net Cash Provided By Used In Operating Activities | -$64.7M | $497.0K | $219.3M | -$268.6M | -$204.2M | -$62.1M | -$80.9M | -$32.8M | -$8.9M | -$9.6M | -$9.4M | $8.4M |
| Net Cash Provided By Used In Investing Activities | -$29.4M | -$96.1M | -$291.1M | $296.6M | -$306.3M | -$125.4M | $119.0M | $43.8M | -$260.8M | -$33.6M | $8.9M | -$15.2M |
| Net Cash Provided By Used In Financing Activities | $7.8M | -$30.7M | $48.7M | -$82.8M | $650.0M | $296.4M | -$1.5M | -$8.2M | $273.2M | $92.4M | -$5.5M | -$641.0K |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $2.5M | $3.1M | $6.2M | $6.7M | $16.4M | $8.7M | $7.2M | $7.9M | $1.3M | $1.4M | $168.0K | $725.0K |
| Proceeds From Sale Of Short Term Investments | $2.13B | $1.77B | $1.34B | $1.52B | $921.4M | $629.4M | $597.0M | $961.7M | $76.3M | $56.6M | $12.2M | $8.9M |
| Payments For Repurchase Of Common Stock | $36.1M | $9.1M | $48.1M | $27.3M | $12.9M | $346.0K | $5.5M | $1.4M | $604.0K | $1.8M | ||
| Payments To Acquire Short Term Investments | $2.74B | $1.85B | $1.63B | $1.20B | $1.36B | $732.9M | $478.1M | $903.6M | $325.0M | $80.9M | ||
| Payments Of Stock Issuance Costs | $83.0K | $29.5M | $8.1M | $739.0K | $8.6M | $12.9M | $1.3M | |||||
| Payments Of Dividends Minority Interest | $1.0M | $9.1M | $25.6M | $9.9M | $1.5M | $1.3M | $1.3M | $1.6M | $564.0K | $590.0K | $1.2M | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $3.6M | -$3.4M | -$6.5M | -$9.5M | $2.4M | $5.5M | -$1.5M | -$1.9M | $2.4M | -$1.8M | ||
| Proceeds From Bank Debt | $30.9M | $36.2M | $61.7M | $17.8M | $26.8M | $26.9M | $32.5M | $25.1M | $3.2M | $8.2M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.52 | $0.04 | $0.12 | -$0.43 | -$0.25 | -$0.18 | -$0.16 | -$1.13 | -$0.43 | $0.20 | -$0.64 | |
| Common Stock Par Or Stated Value Per Share | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $1.00 | $1.00 | $1.00 | $1.00 | |
| Common Stock Shares Issued | 872.3M | 871.6M | 871.3M | 864.8M | 864.5M | 727.7M | 666.9M | 666.6M | 66.4M | 60.7M | 56.5M | |
| Common Stock Shares Authorized | 1.50B | 1.50B | 1.50B | 1.50B | 1.50B | 1.50B | 1.50B | 75.0M | 75.0M | 75.0M | 75.0M | |
| Weighted Average Number Of Shares Outstanding Basic | 858.3M | 855.4M | 849.7M | 847.1M | 792.7M | 697.9M | 665.7M | 66.4M | 61.7M | 59.7M | 54.7M | 52.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 872.9M | 872.8M | 869.2M | 847.1M | 792.7M | 697.9M | 665.7M | 66.4M | 61.7M | 60.0M | 54.7M | 52.6M |
| Earnings Per Share Basic | $0.53 | $0.04 | $0.12 | $-0.43 | $-0.25 | $-0.18 | $-0.16 | $-1.13 | $-0.43 | $0.20 | $-0.64 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling Expense | $36.3M | $48.6M | $53.4M | $43.9M | $37.8M | $11.3M | $13.7M | $17.7M | $19.3M | $18.0M | $10.2M | $4.1M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $14.3M | $30.3M | $29.8M | $39.7M | $36.2M | $16.0M | $9.4M | $11.1M | $2.8M | $2.8M | $401.0K | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition | $11.8M | $27.3M | $23.6M | $33.0M | $19.9M | $7.2M | $2.3M | $3.2M | $1.5M | $1.4M | $233.0K | |
| Costs And Expenses | $587.7M | $673.9M | $819.6M | $834.1M | $684.4M | $424.6M | $351.3M | $306.8M | $294.6M | $262.8M | $188.0M | |
| Treasury Shares Long Term Incentive Plan Held By Trustee | 36.1M | 9.1M | 48.1M | 27.3M | 12.9M | 346.0K | 5.5M | 1.4M | 604.0K | 1.8M | ||
| Stock Issued During Period Value Stock Options Exercised | $1.6M | $790.0K | $5.1M | $174.0K | $2.5M | $593.0K | $251.0K | $3.2M | $380.0K | $426.0K | $1.4M | $2.7M |
| Investment Income Interest | $49.9M | $40.1M | $36.1M | $9.6M | $2.1M | $3.2M | $4.9M | $6.0M | $1.2M | $502.0K | $451.0K | $559.0K |
| Interest Paid Net | $2.5M | $2.5M | $421.0K | $150.0K | $425.0K | $815.0K | $917.0K | $979.0K | $763.0K | $1.6M | $1.2M | |
| Vesting Of Treasury Shares For Ltip | 15.4M | 42.1M | 18.1M | 12.0M | 1.5M | 4.8M | 944.0K | 731.0K | 1.8M |
Most recent annual filing with the SEC: March 5, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.